Michael Aaron Kelly - 10 Aug 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
10 Aug 2023
Net transactions value
$0
Form type
4
Filing time
14 Aug 2023, 17:40:32 UTC
Previous filing
16 Jun 2023
Next filing
15 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEO Common Stock 20,419 10 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +8,353 $0.000000 8,353 10 Aug 2023 Common Stock 8,353 $14.82 Direct
transaction NEO Restricted Stock Unit Award $0 +11,336 $0.000000 11,336 10 Aug 2023 Common Stock 11,336 $0.000000 Direct F1
holding NEO Stock Option (Right to Buy) 2,223 10 Aug 2023 Common Stock 2,223 $37.53 Direct
holding NEO Stock Option (Right to Buy) 3,714 10 Aug 2023 Common Stock 3,714 $40.90 Direct
holding NEO Stock Option (Right to Buy) 13,882 10 Aug 2023 Common Stock 13,882 $8.10 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Once vested, the shares of common stock are not subject to expiration.